Haloperidol Injection, Solution
Product Images NDC 55154-9553

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 55154-9553). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Fk Logo)

FDA Label Image

Structure (Haloperidol Injection Usp Figure 1 Halo Struct)

FDA Label Image

Bag Label (Image 01)

Haloperidol Injection is a prescription medication that is available in a 5mg per mL solution, provided in a single dose vial of 1 mL. Each vial contains 5 mg of haloperidol as the acetate, as well as various other ingredients. It is typically used as a treatment for muscular disorders, although it is recommended that users refer to the product insert for prescribing information, as well as any precautions and warnings. Haloperidol injections should be stored at temperatures between 20° and 25°C (68° and 77°F), and kept away from children. This product is distributed by Cardinal Health.*

FDA Label Image

Table

The given text describes a table showing the adverse reactions occurring in Haloperidol-treated patients in double-blind placebo-controlled clinical trials. The table lists the adverse reactions found in the gastrointestinal and nervous system of the patients. The percentage of patients experiencing each reaction is also shown in the table. The adverse reactions include but not limited to Constipation, Dry mouth, Salivary hypersecretion, Extrapyramidal disorder, Hyperkinesia, Tremor, Hypertonia, Dystonia, Bradykinesia, and Somnolence.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.